论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
AMPH-1 作为重要的肿瘤抑制剂可抑制骨肉瘤进展
Authors Zhang H, Liu Y, Xu K, Mao K, Han W, Xu F, Wan W, Sun Y
Received 24 June 2019
Accepted for publication 22 October 2019
Published 25 November 2019 Volume 2019:11 Pages 9913—9919
DOI https://doi.org/10.2147/CMAR.S220544
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Cristina Weinberg
Peer reviewer comments 2
Editor who approved publication: Dr Ahmet Emre Eskazan
Introduction: Amphiphysin 1 (AMPH-1) is involved in endocytosis, and its expression is upregulated in osteosarcoma compared with osteofibrous dysplasia.
Methods: We investigated the role of AMPH-1 in osteosarcoma cells via both gain-of-function and loss-of-function experiments.
Results: Knockdown of AMPH-1 in osteosarcoma cells promoted cell cycle progression and cell proliferation and attenuated apoptosis. Notably, silencing AMPH-1 increased osteosarcoma progression in a mouse tumor model. The results obtained upon AMPH-1 knockdown and AMPH-1 overexpression indicates that AMPH-1 is involved in regulating MEK/ERK signaling.
Conclusion: These data suggest that AMPH-1 plays an important role in osteosarcoma and may represent a novel therapeutic target for osteosarcoma treatment.
Keywords: AMPH-1, osteosarcoma, ERK signaling pathway
